A small, gentle meal is usually easier than a heavy meal
Sound mechanistic evidence supports the need for further research on the GLP1-RAs/SGLT2is combinations ability to modify specific risk outcomes, such as cardiovascular risk and the progression of diabetic kidney disease
This risk was notably higher in procedures involving propofol sedation, specifically upper GI endoscopies, with no significant risk noted in lower GI procedures
Patientreported outcome assessments are conducted across the TRIUMPH program
[7] [8] By activating the GLP-1 receptor, retatrutide promotes insulin secretion, reduces appetite, and slows gastric emptying
Weight, appetite, and future health risks do not always show up on a lab report